Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$55.64M-17.1%-$47.51M+10.2%-$52.9M-13.4%-$46.63M+5.8%-$49.5M-14.3%
$23.1M+19.9%$19.27M+2.4%$18.81M+18.5%$15.88M+23.5%$12.86M+21.8%
-$44.19M-74.0%-$25.39M+4.6%-$26.62M-14.2%-$23.31M+42.2%-$40.35M-114%
$57.05M-$246.35M-556%$54.04M+118%$24.81M
$4.29M-20.6%$5.4M-3.1%$5.57M+28.6%$4.33M-6.1%$4.62M+21.2%
-$5.4M$189.3M$32.5M-15.2%
$7.92M$0+100%-$83.36M-382%$29.55M+74.3%$16.96M-59.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Rhythm Pharmaceuticals, Inc. generate?
Rhythm Pharmaceuticals, Inc. (RYTM) generated -$119.5M in operating cash flow over the trailing twelve months.
Where does Rhythm Pharmaceuticals, Inc.'s cash flow data come from?
Every line is extracted from Rhythm Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.